News
Posted: March 17, 2020 | News, Press
Amsino Covid19 Update Letter to Customers
Dear Valued Customers
As COVID-19 (Coronavirus) spread escalates globally, I wanted to reach out and let you know how Amsino is handling this unprecedented crisis. We at Amsino are committed to the continuity of serving our customers, while at the same time ensuring the health and wellness of our employees.
On January 28, 2020, we established a COVID-19 task force. We have since put many precautionary measures into action aiming at protecting our employees and minimizing the impact on our customers.
Manufacturing Operations Management
As Coronavirus spread in China has stabilized, I am pleased to inform you that all Amsino facilities and manufacturing plants in China are currently operating on a normal schedule. There are currently no diagnoses within Amsino employees in China. Almost all Amsino employees have returned to work. Specifically,
-
Amsino office employees in Shanghai returned from their Chinese new year holiday and resumed work on February 10, 2020.
-
Amsino Medical (Shanghai) Co., Ltd., resumed production on February 8, and is currently operating at 100% capacity.
-
Amsino Medical (Kunshan) Co., Ltd., resumed production on February 15, and is operating at 95% capacity. We expect the capacity will increase to 100% by Friday, March 20.
-
Shanghai Regent Medical Technology Co., Ltd., resumed production on February 10 and is currently operating at 100% capacity.
In the US, Amsino Healthcare, Inc. based in Vernon Hills, Illinois has been operating normally since the outbreak of Coronavirus here in the US and we will continue to monitor closely the development of the spread of the Coronavirus and changes in governmental guidelines and directives.
Social Responsibilities
Since the outbreak of Covid-19, Amsino has actively joined in the fight against the coronavirus in China. Amsino China has donated 1.15 million Yuan in medical products directly to more than 20 frontline hospitals in Wuhan, Hubei Province, Shanghai, and Jiangsu areas.
As a global medical device company, Amsino takes its responsibility to maintain manufacturing and an uninterrupted supply to our customers during this crisis very seriously. Through efforts, our China based manufacturing sites have managed to operate at full capacity and our US plant has been operating normally. Frontline employees in our distribution centers, sales and marketing function, and our customer service, and other critical operations will remain at work in facilities and continuing to deliver products to help combat the coronavirus.
Supply Chain Management
We are actively monitoring our global supplier network and freight lanes to identify any risks of business interruption. At this point, more than 90% of our suppliers are operating on normal schedules.
Container shipping out of Shanghai port is getting back to normal and we are catching up on previous delayed shipments.
Amsino in the US has been operating on regular delivery schedules. We will fully utilize our available resources and spare no effort to fulfill customer orders.
Amsino will open a new distribution center in Aurora, Illinois in the first week of April, 2020. With this new distribution center, we should improve our lead time for most of our customers in the US, especially our customers in the east coast. At this point, we are still on schedule with the opening of this distribution center, despite of the challenges we are facing.
Employee Safety
We put employee safety first. In addition to the measures we have taken and in compliance with the recent CDC guidelines, we have halted non-essential business travel for our employees and restricted onsite visits to our facilities. We make exceptions on a case by case basis. We have online communication tools ready to conduct virtual meetings. We feel this is an effective way to conduct business while simultaneously minimizing health risks. We will closely monitor the situation and may take additional measures for the safety of our employees.
Business Continuity Management
We are reviewing our business continuity management system so that we may continue to provide you with an outstanding level of service amid the escalating spread of COVID-19. Our global sales and marketing team in North America, Latin America, EMEA, APAC, China, and our customer service will remain active even in the event of a forced closure.
We are again committed to the continuity of serving our global customers. As we continue to monitor the situation, additional changes in our operations may be necessary in order to comply with government guidelines and directives. We will keep you posted as we navigate through this challenging and uncertain time.
If you have any questions or concerns, please feel free to contact us.
Best Regards
Richard Y. Lee, Ph.D.
CEO
Amsino International, Inc.